Pieter Depuydt
Overview
Explore the profile of Pieter Depuydt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
3428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
De Waele J, Leroux-Roels I, Depuydt P
Intensive Care Med
. 2023 May;
49(8):979-981.
PMID: 37209122
No abstract available.
12.
De Corte T, Verhaeghe J, Dhaese S, Van Vooren S, Boelens J, G Verstraete A, et al.
Ann Intensive Care
. 2023 Apr;
13(1):35.
PMID: 37119362
Background: Several studies have indicated that commonly used piperacillin-tazobactam (TZP) and meropenem (MEM) dosing regimens lead to suboptimal plasma concentrations for a range of pharmacokinetic/pharmacodynamic (PK/PD) targets in intensive care...
13.
Vanoverschelde A, Van Hoey C, Buyle F, Den Blauwen N, Depuydt P, Van Braeckel E, et al.
BMC Pulm Med
. 2023 Apr;
23(1):138.
PMID: 37098509
Background: The use of antibiotics in mild to severe acute exacerbations of chronic obstructive pulmonary disease (COPD) remains controversial. Aim: To explore in-hospital antibiotic use in severe acute exacerbations of...
14.
De Smet M, Bogaert S, Schauwvlieghe A, Dendooven A, Depuydt P, Druwe P
Front Med (Lausanne)
. 2022 Dec;
9:1096900.
PMID: 36579154
Hemophagocytic lymphohistiocytosis may occur in patients with genetic predisposition and in sporadic cases due to malignancy or infection. We describe a 49-year old man with hemorrhagic fever, type 1 respiratory...
15.
Bosteels C, Van Damme K, De Leeuw E, Declercq J, Maes B, Bosteels V, et al.
Cell Rep Med
. 2022 Dec;
3(12):100833.
PMID: 36459994
GM-CSF promotes myelopoiesis and inflammation, and GM-CSF blockade is being evaluated as a treatment for COVID-19-associated hyperinflammation. Alveolar GM-CSF is, however, required for monocytes to differentiate into alveolar macrophages (AMs)...
16.
Peperstraete H, Steenhout A, De Somer F, Depuydt P, Hoste E, Van Herzeele I
BMC Med Educ
. 2022 Nov;
22(1):786.
PMID: 36376826
Background: Education in ECMO starts with basic theory and physiology. For this type of training, self-assessment e-learning modules may be beneficial. The aim of this study was to generate consensus...
17.
Zwaenepoel B, Vandewiele K, Peperstraete H, De Ryck F, Vanpeteghem C, Malfait T, et al.
Perfusion
. 2022 Aug;
38(8):1577-1583.
PMID: 35969115
Introduction: Coronavirus disease 2019 (COVID-19) leads to thoracic complications requiring surgery. This is challenging, particularly in patients supported with venovenous extracorporeal membrane oxygenation (VV-ECMO) due to the need for continuous...
18.
De Leeuw E, Van Damme K, Declercq J, Bosteels C, Maes B, Tavernier S, et al.
Respir Res
. 2022 Aug;
23(1):202.
PMID: 35945604
Background: The efficacy and safety of complement inhibition in COVID-19 patients is unclear. Methods: A multicenter randomized controlled, open-label trial. Hospitalized COVID-19 patients with signs of systemic inflammation and hypoxemia...
19.
van Charante F, Wieme A, Rigole P, De Canck E, Ostyn L, Grassi L, et al.
Biofilm
. 2022 Jun;
4:100079.
PMID: 35720435
In patients with acute respiratory failure, mechanical ventilation through an endotracheal tube (ET) may be required to correct hypoxemia and hypercarbia. However, biofilm formation on these ETs is a risk...
20.
Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, et al.
ERJ Open Res
. 2022 Apr;
8(2).
PMID: 35415186
Background: Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are needed to understand their recovery trajectory and additional care needs. Methods: A prospective observational multicentre cohort study was carried...